Smart Hybrid Nanocomposite for Photodynamic Inactivation of Cancer Cells with Selectivity

Jeong Wook Hwang, Seung Jin Jung, Taek Chin Cheong, Yuri Kim, Eon Pil Shin, Il Heo, Gwanghun Kim, Nam Hyuk Cho, Kang Kyun Wang, Yong Rok Kim

Research output: Contribution to journalArticle

Abstract

Photodynamic therapy has been efficiently applied for cancer therapy. Here, we have fabricated the folic acid (FA)- and pheophorbide A (PA)-conjugated FA/PA@Fe3O4 nanoparticle (smart hybrid nanocomposite, SHN) to enhance the photodynamic inactivation (PDI) of specific cancer cells. SHN coated with the PDI agent is designed to have selectivity for the folate receptor (FR) expressed on cancer cells. Structural characteristics and morphology of the fabricated MNPs were studied with X-ray diffraction and scanning electron microscopy. The photophysical properties of SHN were investigated with absorption, emission spectroscopies, and Fourier transform infrared spectroscopy. In addition, the magnetic property of Fe3O4 nanoparticle (MNP) can be utilized for the collection of SHNs by an external magnetic field. The photofunctionality was given by the photosensitizer, PA, which generates reactive oxygen species by irradiation of visible light. Generation of singlet oxygen was directly evaluated with time-resolved phosphorescence spectroscopy. Biocompatibility and cellular interaction of SHN were also analyzed by using various cancer cells, such as KB, HeLa, and MCF-7 cells which express different levels of FR on the surface. Cellular adsorption and the PDI effect of SHN on the various cancer cells in vitro were correlated well with the surface expression levels of FR, suggesting potential applicability of SHN on specific targeting and PDI of FR-positive cancers.

Original languageEnglish
Pages (from-to)6776-6783
Number of pages8
JournalJournal of Physical Chemistry B
Volume123
Issue number31
DOIs
Publication statusPublished - 2019 Aug 8

Fingerprint

Folic Acid
deactivation
Nanocomposites
nanocomposites
selectivity
cancer
Cells
folic acid
therapy
Nanoparticles
Phosphorescence
nanoparticles
Singlet Oxygen
Photodynamic therapy
Oxygen
Photosensitizing Agents
Photosensitizers
Acids
Emission spectroscopy
biocompatibility

All Science Journal Classification (ASJC) codes

  • Physical and Theoretical Chemistry
  • Surfaces, Coatings and Films
  • Materials Chemistry

Cite this

Hwang, Jeong Wook ; Jung, Seung Jin ; Cheong, Taek Chin ; Kim, Yuri ; Shin, Eon Pil ; Heo, Il ; Kim, Gwanghun ; Cho, Nam Hyuk ; Wang, Kang Kyun ; Kim, Yong Rok. / Smart Hybrid Nanocomposite for Photodynamic Inactivation of Cancer Cells with Selectivity. In: Journal of Physical Chemistry B. 2019 ; Vol. 123, No. 31. pp. 6776-6783.
@article{61b8d9e8ee3e48eeb5f742493b87d5f0,
title = "Smart Hybrid Nanocomposite for Photodynamic Inactivation of Cancer Cells with Selectivity",
abstract = "Photodynamic therapy has been efficiently applied for cancer therapy. Here, we have fabricated the folic acid (FA)- and pheophorbide A (PA)-conjugated FA/PA@Fe3O4 nanoparticle (smart hybrid nanocomposite, SHN) to enhance the photodynamic inactivation (PDI) of specific cancer cells. SHN coated with the PDI agent is designed to have selectivity for the folate receptor (FR) expressed on cancer cells. Structural characteristics and morphology of the fabricated MNPs were studied with X-ray diffraction and scanning electron microscopy. The photophysical properties of SHN were investigated with absorption, emission spectroscopies, and Fourier transform infrared spectroscopy. In addition, the magnetic property of Fe3O4 nanoparticle (MNP) can be utilized for the collection of SHNs by an external magnetic field. The photofunctionality was given by the photosensitizer, PA, which generates reactive oxygen species by irradiation of visible light. Generation of singlet oxygen was directly evaluated with time-resolved phosphorescence spectroscopy. Biocompatibility and cellular interaction of SHN were also analyzed by using various cancer cells, such as KB, HeLa, and MCF-7 cells which express different levels of FR on the surface. Cellular adsorption and the PDI effect of SHN on the various cancer cells in vitro were correlated well with the surface expression levels of FR, suggesting potential applicability of SHN on specific targeting and PDI of FR-positive cancers.",
author = "Hwang, {Jeong Wook} and Jung, {Seung Jin} and Cheong, {Taek Chin} and Yuri Kim and Shin, {Eon Pil} and Il Heo and Gwanghun Kim and Cho, {Nam Hyuk} and Wang, {Kang Kyun} and Kim, {Yong Rok}",
year = "2019",
month = "8",
day = "8",
doi = "10.1021/acs.jpcb.9b04301",
language = "English",
volume = "123",
pages = "6776--6783",
journal = "Journal of Physical Chemistry B",
issn = "1520-6106",
number = "31",

}

Hwang, JW, Jung, SJ, Cheong, TC, Kim, Y, Shin, EP, Heo, I, Kim, G, Cho, NH, Wang, KK & Kim, YR 2019, 'Smart Hybrid Nanocomposite for Photodynamic Inactivation of Cancer Cells with Selectivity', Journal of Physical Chemistry B, vol. 123, no. 31, pp. 6776-6783. https://doi.org/10.1021/acs.jpcb.9b04301

Smart Hybrid Nanocomposite for Photodynamic Inactivation of Cancer Cells with Selectivity. / Hwang, Jeong Wook; Jung, Seung Jin; Cheong, Taek Chin; Kim, Yuri; Shin, Eon Pil; Heo, Il; Kim, Gwanghun; Cho, Nam Hyuk; Wang, Kang Kyun; Kim, Yong Rok.

In: Journal of Physical Chemistry B, Vol. 123, No. 31, 08.08.2019, p. 6776-6783.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Smart Hybrid Nanocomposite for Photodynamic Inactivation of Cancer Cells with Selectivity

AU - Hwang, Jeong Wook

AU - Jung, Seung Jin

AU - Cheong, Taek Chin

AU - Kim, Yuri

AU - Shin, Eon Pil

AU - Heo, Il

AU - Kim, Gwanghun

AU - Cho, Nam Hyuk

AU - Wang, Kang Kyun

AU - Kim, Yong Rok

PY - 2019/8/8

Y1 - 2019/8/8

N2 - Photodynamic therapy has been efficiently applied for cancer therapy. Here, we have fabricated the folic acid (FA)- and pheophorbide A (PA)-conjugated FA/PA@Fe3O4 nanoparticle (smart hybrid nanocomposite, SHN) to enhance the photodynamic inactivation (PDI) of specific cancer cells. SHN coated with the PDI agent is designed to have selectivity for the folate receptor (FR) expressed on cancer cells. Structural characteristics and morphology of the fabricated MNPs were studied with X-ray diffraction and scanning electron microscopy. The photophysical properties of SHN were investigated with absorption, emission spectroscopies, and Fourier transform infrared spectroscopy. In addition, the magnetic property of Fe3O4 nanoparticle (MNP) can be utilized for the collection of SHNs by an external magnetic field. The photofunctionality was given by the photosensitizer, PA, which generates reactive oxygen species by irradiation of visible light. Generation of singlet oxygen was directly evaluated with time-resolved phosphorescence spectroscopy. Biocompatibility and cellular interaction of SHN were also analyzed by using various cancer cells, such as KB, HeLa, and MCF-7 cells which express different levels of FR on the surface. Cellular adsorption and the PDI effect of SHN on the various cancer cells in vitro were correlated well with the surface expression levels of FR, suggesting potential applicability of SHN on specific targeting and PDI of FR-positive cancers.

AB - Photodynamic therapy has been efficiently applied for cancer therapy. Here, we have fabricated the folic acid (FA)- and pheophorbide A (PA)-conjugated FA/PA@Fe3O4 nanoparticle (smart hybrid nanocomposite, SHN) to enhance the photodynamic inactivation (PDI) of specific cancer cells. SHN coated with the PDI agent is designed to have selectivity for the folate receptor (FR) expressed on cancer cells. Structural characteristics and morphology of the fabricated MNPs were studied with X-ray diffraction and scanning electron microscopy. The photophysical properties of SHN were investigated with absorption, emission spectroscopies, and Fourier transform infrared spectroscopy. In addition, the magnetic property of Fe3O4 nanoparticle (MNP) can be utilized for the collection of SHNs by an external magnetic field. The photofunctionality was given by the photosensitizer, PA, which generates reactive oxygen species by irradiation of visible light. Generation of singlet oxygen was directly evaluated with time-resolved phosphorescence spectroscopy. Biocompatibility and cellular interaction of SHN were also analyzed by using various cancer cells, such as KB, HeLa, and MCF-7 cells which express different levels of FR on the surface. Cellular adsorption and the PDI effect of SHN on the various cancer cells in vitro were correlated well with the surface expression levels of FR, suggesting potential applicability of SHN on specific targeting and PDI of FR-positive cancers.

UR - http://www.scopus.com/inward/record.url?scp=85070544378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070544378&partnerID=8YFLogxK

U2 - 10.1021/acs.jpcb.9b04301

DO - 10.1021/acs.jpcb.9b04301

M3 - Article

C2 - 31310131

AN - SCOPUS:85070544378

VL - 123

SP - 6776

EP - 6783

JO - Journal of Physical Chemistry B

JF - Journal of Physical Chemistry B

SN - 1520-6106

IS - 31

ER -